Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by jopatcloon Dec 17, 2024 6:56am
29 Views
Post# 36365672

RE:RE:Post Angiopro and See Bart comment on post SassyWiređź’ˇ

RE:RE:Post Angiopro and See Bart comment on post SassyWiređź’ˇ
''With the FDA's Breakthrough Designation, companies can secure faster reimbursement across the U.S., offering quicker market access—a game-changer for startups and investors alike.''
2 weeks to 2025 & now the moment we've finally been waiting for FDA V4.0 for our patience and trust with Ventripoint all these years.
2025 years of Ventripoint for children's health and we long for them with Ventripoint.

Voir Angio Consult GmbH
Angio Consult GmbH soutient ceci
MedTech World16821 abonnsIl y a 19 heures
At hashtagMedTechMalta2024, Benjamin Joas Rieck, CEO of Angio Consult GmbH, highlighted the importance of having a clear path to commercialization before treating your first patient or raising funds.

With the FDA's Breakthrough Designation, companies can secure faster reimbursement across the U.S., offering quicker market access—a game-changer for startups and investors alike.
jopatclo wrote: Sorry bd translation copy.GOOD COPY TRANSLATED =

Post Angiopro and See Bart comment on post SavvyWire

jopatclo wrote: Interesting and remember post ( Bart Hendrikx on SavvyWire is the first and only sensor-guided solution designed specifically to optimize TAVR.)
Photo du profil de Bart
Bart Hendriks aime ceci
SavvyWire: Innovation You Can Trust

Why settle for less when you can have it all? hashtagSavvyWire’s pre-shaped pressure guidewire offers:
Engineered stability for valve delivery
Advanced fiber optic sensors for accuracy
Smart integration with OptoMonitor for real-time insights

Transform your TAVR procedures with SavvyWire’s cutting-edge design. https://lnkd.in/eyXn-3tP

hashtagSavvyWire hashtagTAVRInnovation hashtagPrecisionHealth hashtagCardiology

Remember post 
Photo du profil de Bart
Bart Hendriks aime ceci
 
One Wire. Endless Possibilities.

hashtagSavvyWire is the first and only sensor-guided solution designed specifically to optimize TAVR. From pre-procedure planning to real-time monitoring, it’s all about delivering predictable and efficient outcomes.

Imagine the possibilities when one wire does it all! Explore how SavvyWire is redefining TAVI procedures. https://lnkd.in/ePzr5YsP
Aucune description alternative pour cette image




<< Previous
Bullboard Posts
Next >>